Merck, 1463530006, Modified Tween®Letheen Broth

General description
Modified Tween®-Letheen-Broth has significantly improved nutritional content compared to the Letheen-Broth, with the increase of meat peptone concentration and the addition of casein and yeast extract as a source of vitamins. The efficacy of the inactivating agents is also improved by the addition of sodium thiosulfate (neutralizes iodine and chlorine) and sodium bisulfite (neutralizes formaldehyde, formaldehyde releasers, and Glutaraldehyde).
Application
Modified Tween® -Letheen-Broth is designed for the enumeration of fastidious microorganisms in the presence of disinfectant residues.
Features and Benefits
Our ready to use media provide the highest level of quality and testing confidence. They have been formulated and tested to meet the pharmacopoeia requirements. Sterility testing media and rinse solutions are manufactured in an ISO 9001, environmentally controlled production center. Each lot undergoes a stringent quality control (QC) procedure, including pH, sterility and growth promotion tests. Our manufacturing approach ensures the highest level of clarity for our media and rinsing fluids, therefore improving accuracy and significantly reducing the risk of incorrect interpretation and false results.
Other Notes
Production will take place at Millipore SAS in Molsheim, France. Deliveries will be executed in accordance with the terms and conditions of MLS RTU GmbH. A minimum order quantity is required to process the order. Once the order is placed and confirmed, Merck will ensure product delivery within a maximum timeframe of 10 to 12 weeks. The terms and conditions of Merck KGaA apply to both Millipore SAS and MLS RTU GmbH and can be accessed through the following link: Standard Terms & conditions
This medium can be modified and/or supplemented based on the required performance criteria.
Legal Information
TWEEN is a registered trademark of Croda International PLC
Disclaimer
This item is created at the customer′s request as a customized product and will not be developed or qualified in accordance with the Merck Product Development Process.